ProcDNA is attending the Biopharma Medical Affairs Nexus Conference 2026 in Philadelphia. Our team will be sharing how Data and AI can help reimagine scientific engagement across Medical Affairs from planning to post engagement insights. If you are attending, connect with Harpreet Singh and Shivika Singla at the conference.

Exploring how Data and AI can reimagine scientific engagement across Medical Affairs.

Data & AI in Medical Affairs

From planning to post engagement insights a full-cycle view of scientific engagement.

Scientific Engagement Planning

Leveraging data to measure and derive insights after every scientific engagement.

Post Engagement Insights

How AI-driven approaches are reshaping the way Medical Affairs teams engage with HCPs.

Reimagining HCP Engagement

Harpreet Singh

Shivika Singla

Biopharma Medical Affairs Nexus Conference 2026 

We were at Reuters Pharma USA 2026, engaging with leaders across commercial, medical, and analytics teams on how the industry is evolving. Conversations focused on how organizations are moving from insight generation to real execution by better connecting data, analytics, and field strategy. It was a valuable opportunity to exchange perspectives, share our experience, and understand how leading teams are driving more consistent and measurable impact across commercial functions.

Conversations focused on how organizations are moving beyond reporting to enable faster, more consistent decision making across commercial teams. 

Execution-focused analytics in commercial pharma 

Discussions highlighted how AI is being applied across forecasting, targeting, and engagement, with a clear focus on practical implementation and measurable outcomes. 

AI adoption in real-world use cases 

Leaders shared how omnichannel approaches are becoming more precise, with better use of data to improve timing, personalization, and channel effectiveness. 

Evolving HCP engagement strategies 

There was strong emphasis on integrating CRM, MDM, and analytics to create a unified view that supports better execution and cross functional alignment. 

Importance of connected data ecosystems 

Ashish Agrawal 

Varsha Eluri

Adyant Jha

Akanksha Nangia

Reuters Pharma USA 2026

Dive into the session to explore how Generative AI can revolutionize the life sciences industry while maintaining top-notch security. Gain insights into designing robust Gen AI applications, implementing critical security measures, and leveraging collaboration to enhance innovation and safety. Click to watch the recording and take the first step toward building secure, cutting-edge Gen AI solutions tailored for the life sciences industry!

Gain a roadmap to build a robust IT infrastructure that accelerates clinical timelines and boosts project agility.

IT Blueprint for Clinical Speed

Learn strategies to implement scalable IT systems that drive faster product launches and operational efficiency.

Scalable Systems Mastery

Unlock actionable insights on leveraging data analytics to enhance decision-making and improve patient outcomes.

Data-Driven Decision Power

Acquire methods to streamline IT operations, cut inefficiencies, and accelerate project delivery.

Tools for IT Optimization

Discover how to integrate advanced technologies that enhance patient care and engagement.

Tech for Patient-Centric Care

Learn to prioritize IT investments that drive scalability, innovation, and competitive advantage.

Strategic IT Investment Insights

Gunmeet Singh

Son Ly

John Cummings

Set up Scalable IT Systems for Quicker Product Launches

Join us at Pharma USA 2025, where industry leaders, innovators, and changemakers come together to navigate disruption with purpose. This year, we're not just discussing change - we're defining the strategies that will drive real-world impact.  At Reuters Pharma USA, the industry's annual check-up evolves into a full-scale strategic blueprint for success. Expect deep-dive discussions, hands-on sessions, and cutting-edge insights designed to empower commercial, marketing, medical affairs, market access, patient engagement, and RWE leaders.

The pharmaceutical industry is undergoing rapid transformations driven by technological advancements, regulatory shifts, and evolving patient expectations. This conference will explore proactive strategies to navigate these disruptions and stay ahead in a dynamic environment.

Navigating Pharma's Changing Landscape

Balancing human-centric approaches with cutting-edge technology and data-driven decision-making is crucial for driving better patient outcomes and commercial success. Sessions will highlight practical ways to integrate these elements effectively.

Human-Led, Tech-Enabled, Data-Driven Strategies

With continuous industry evolution, staying competitive requires forward-thinking strategies. The conference will provide insights on anticipating and preparing for future changes to ensure long-term success in a rapidly shifting landscape.

Future-Proofing Pharma Strategies

True impact goes beyond organizational restructuring - it’s about achieving real improvements in patient outcomes. Discussions will focus on innovative approaches across commercial strategy, marketing, medical affairs, patient engagement, RWE, and market access to drive meaningful change.

Transforming Outcomes, not just Structures

Roshan Alvares

Reuters Pharma USA 2025

ProcDNA attended Future Pharma 2026 in Boston, the world's leading pharma commercialization event bringing together marketing, sales, and commercial leaders. The two-day conference focused on omnichannel engagement, patient-centric strategies, and the future of pharma commercialization through peer-led discussions and collaborative formats.

Explored how pharma teams can deliver seamless HCP and patient journeys through precision, optichannel strategies.

Omnichannel Engagement

Discussed smarter strategies and resources for maximizing launch success in a competitive pharma landscape.

Commercial Launch Excellence

Examined how AI and digital tools are advancing patient engagement and reshaping commercialization models.

AI & Digital Health Innovation

Gained real frameworks and proven case studies to elevate customer and patient experience focused on action, not experimentation.

Execution-Focused Strategies

Saurabh Singh

Future Pharma 2026

ProcDNA is attending the PMSA Annual Conference 2026 in New Orleans. Our team will be sharing how advanced analytics and AI can help overcome diagnostic ambiguity and identify patients in ultra-rare diseases. If you are attending, connect with Supriye, Rohit M, Akansha Nangia, and Varsha at the conference.

How AI can help overcome diagnostic ambiguity and prevalence inflation in ultra-rare diseases.

Rare Disease Patient Identification

How learning systems are integrating commercial, medical, and access analytics into a single forecasting framework.

Next-Gen Forecasting

How generative AI agents are accelerating commercial analytics and semantic data discovery.

GenAI-Powered Analytics

How AI combined with real-world data enables earlier prediction of disease progression.

Real-World Data & Precision Targeting

How claims data is being used to sharpen physician segmentation and predict brand activation.

Claims-Based Segmentation

Why synthetic data is emerging as a credible, usable substitute for real-world datasets.

Synthetic Data in Pharma

Supriye Jain

Rohit Madaan

Akansha Nangia

PMSA 2026

Explore key strategies and gain actionable insights to build innovative, secure, and scalable solutions using Generative AI models. This session will guide you through best practices, real-world applications, and the importance of safeguarding data while leveraging the transformative potential of Gen AI. Click the button below to request the recording and unlock the knowledge shared during this insightful webinar.

Explore the designing of a robust Gen AI application for specific business use cases by leveraging Open AI, Gemini or DBRX open-source models. 

Design a Gen AI application

Establish security measures to fortify your Gen AI solutions.

Security Guardrails for Gen AI Solutions

Learn how to continuously monitor and adapt your solutions to stay ahead of emerging threats. 

Continuous Monitoring and Adaptation

Explore the importance of collaboration and knowledge sharing in maintaining secure Gen AI solutions. 

Collaboration and Knowledge Sharing

Ankush Kumar

Ankush Batra

Building your Life Sciences Solutions securely with Gen AI Models

Building your life sciences solutions securely with Gen AI models

In this insightful session at Fierce Pharma, discover practical strategies empowering Medical Science Liaisons (MSLs) to engage Key Opinion Leaders (KOLs) more effectively. This session delves into bridging the gap between access and meaningful impact, equipping MSLs with the tools and confidence to build credible, relevant scientific relationships that drive positive outcomes in pharmaceutical engagement.  Watch the full video to learn how ProcDNA is revolutionizing MSL KOL interactions for greater impact and relevance.

Shifting MSL engagement from merely accessing KOLs to creating meaningful, impactful scientific relationships that drive real world outcomes.

From Access to Impact

Equipping MSLs with skills and strategies to engage KOLs confidently and establish themselves as trusted scientific partners.

Building MSL Confidence and Credibility

Identifying and focusing on KOLs who align closely with therapeutic goals and organizational priorities to maximize engagement relevance.

Strategic KOL Prioritization

Leveraging insights and digital tools to tailor interactions that resonate with individual KOLs’ interests and scientific priorities.

Data-Driven Personalization

Establishing trust by maintaining transparent, evidence based, and ethically sound scientific communication with KOLs.

Trust through Transparent Dialogue

Tracking engagement effectiveness by going beyond interaction counts to assess influence on decision making and outcomes.

Measuring Engagement Success

Bryan Goldberg

Fierce Pharma Week 2025

ProcDNA is attending the Nasscom GCC Summit 2026 in Mumbai. Our team will be connecting with GCC leaders to discuss how India's Global Capability Centers are evolving into AI-first, business-embedded partners. If you are attending, connect with Shailesh Tiwari at the conference.

How GCCs are shifting from delivery hubs to owning outcomes, products, and business decisions end to end.

From Execution to Ownership

Why AI is redefining India's competitive advantage beyond scale and cost arbitrage.

AI as the Great Leveller

How GCCs are learning to quantify and communicate their impact beyond cost savings.

Strategic Value Articulation

What it takes for GCCs to coordinate work across humans, platforms, and intelligent agents.

The Agentic Enterprise

How organizations are rethinking roles, career pathways, and governance for an AI-driven workforce.

Talent & Operating Model Redesign

Why emerging cities and regional ecosystems are becoming the next frontier for GCC growth.

Beyond the Established Hubs

Shailesh Tiwari

Nasscom GCC Summit 2026

ProcDNA is attending Pharma Market Research Conference (PMRC) West 2026. Our team, alongside Neurocrine Biosciences, will be sharing how synthetic HCP personas grounded in real segmentation research can serve as an on-demand sounding board for creative evaluation, messaging decisions, and campaign architecture. If you are attending, connect with Dev, Rohit M, and Aritra Das at the conference.

How AI-built personas, grounded in real segmentation data, give brand teams an on-demand sounding board for decisions.

Synthetic HCP Personas 

How synthetic personas help teams pressure-test creative concepts before they reach the field.

Creative Evaluation at Speed

How grounded personas sharpen confidence in messaging choices without waiting on new primary research.

Messaging Decisions 

How synthetic research inputs are shaping how campaigns are structured from the ground up.

Campaign Architecture 

Why human judgment and context remain central even as AI accelerates insight generation.

AI-Human Balance

How faster, more integrated insights are driving quicker, more confident commercial decisions.

From Insight to Action

Aritra Das

Dev (Devprakash) Satpathy

PMRC West 2026

We were at PMRC 2026, connecting with market research and insights leaders across the pharmaceutical industry. Conversations explored how the role of insights is evolving from supporting decisions to actively shaping commercial and brand strategy. It was a valuable opportunity to exchange perspectives and better understand how organizations are making insights more relevant, timely, and actionable across the business. 

Discussions highlighted how market research is becoming more embedded within commercial strategy, moving beyond standalone studies. 

Evolving role of market research 

There was a clear emphasis on stronger collaboration between insights, brand, and field teams to ensure findings are applied in real world decision making. 

Bringing insights closer to execution 

Leaders shared how combining traditional research with real world data is helping build a more complete and practical understanding of customer behavior. 

Blending primary research with real-world data 

Organizations are adopting new approaches to deliver insights faster, with a focus on keeping pace with changing business needs. 